| Authors: |
Huels DJ; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Bruens L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT, Utrecht, The Netherlands.; Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands.; Center for Molecular Medicine, Oncode Institute, University Medical Center Utrecht, 3584 CG, Utrecht, The Netherlands., Hodder MC; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Cammareri P; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Campbell AD; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Ridgway RA; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Gay DM; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Solar-Abboud M; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Faller WJ; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Nixon C; CRUK Beatson Institute, Glasgow, G61 1BD, UK., Zeiger LB; CRUK Beatson Institute, Glasgow, G61 1BD, UK., McLaughlin ME; Oncology Translational Research, Novartis Institutes for Biomedical Research, Cambridge, MA, 02139, USA., Morrissey E; MRC Weatherall Institute of Molecular Medicine University of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK., Winton DJ; CRUK Cambridge Institute, Cambridge, CB2 0RE, UK., Snippert HJ; Center for Molecular Medicine, Oncode Institute, University Medical Center Utrecht, 3584 CG, Utrecht, The Netherlands., van Rheenen J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584 CT, Utrecht, The Netherlands.; Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands., Sansom OJ; CRUK Beatson Institute, Glasgow, G61 1BD, UK. o.sansom@beatson.gla.ac.uk.; Institute of Cancer Sciences (ICS), University of Glasgow, Glasgow, G12 8QQ, UK. o.sansom@beatson.gla.ac.uk. |
